Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marsha L Fox

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Circulation. Cardiovascular Interventions|August 26, 2010
The Platelet Activity After Clopidogrel Termination (PACT) studyAndrew L Frelinger, Marc R Barnard, Marsha L Fox, et al.
Circulation|June 21, 2006
Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistanceAndrew L Frelinger, Mark I Furman, Matthew D Linden, et al.
Thrombosis Research|May 29, 2007
Cystic fibrosis heterozygotes do not have increased platelet activationInge Tarnow, Alan D Michelson, Andrew L Frelinger, et al.
Circulation|December 10, 2009
Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterizationAndrew L Frelinger, YouFu Li, Matthew D Linden, et al.
Thrombosis and Haemostasis|June 29, 2007
The active metabolite of prasugrel inhibits ADP-stimulated thrombo-inflammatory markers of platelet activation: Influence of other blood cells, calcium, and aspirinAndrew L Frelinger, Joseph A Jakubowski, Youfu Li, et al.
American Heart Journal|February 22, 2003
Quantification of abciximab-induced platelet inhibition is assay dependent: a comparative study in patients undergoing percutaneous coronary interventionMark I Furman, Dean J Kereiakes, Lori A Krueger, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Circulation. Cardiovascular Interventions|August 26, 2010
The Platelet Activity After Clopidogrel Termination (PACT) studyAndrew L Frelinger, Marc R Barnard, Marsha L Fox, et al.
Circulation|June 21, 2006
Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistanceAndrew L Frelinger, Mark I Furman, Matthew D Linden, et al.
Thrombosis Research|May 29, 2007
Cystic fibrosis heterozygotes do not have increased platelet activationInge Tarnow, Alan D Michelson, Andrew L Frelinger, et al.
Circulation|December 10, 2009
Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterizationAndrew L Frelinger, YouFu Li, Matthew D Linden, et al.
Thrombosis and Haemostasis|June 29, 2007
The active metabolite of prasugrel inhibits ADP-stimulated thrombo-inflammatory markers of platelet activation: Influence of other blood cells, calcium, and aspirinAndrew L Frelinger, Joseph A Jakubowski, Youfu Li, et al.
American Heart Journal|February 22, 2003
Quantification of abciximab-induced platelet inhibition is assay dependent: a comparative study in patients undergoing percutaneous coronary interventionMark I Furman, Dean J Kereiakes, Lori A Krueger, et al.
Pageof 1